By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cellectar Biosciences (Formerly Known As Novelos Therapeutics, Inc.)  

3301 Agriculture Drive

Madison  Wisconsin  53716  U.S.A.
Phone: 608-441-8120 Fax: 608-441-8120



Drug Discovery

Company News
Cellectar Biosciences  (NVLT) Closes On $3.3 Million Financing 10/2/2015 7:29:24 AM
Cellectar Biosciences  (NVLT) Awarded $2.3 Million National Cancer Institute Fast-Track SBIR Grant To Advance Phospholipid Drug Conjugate (PDC) Delivery Platform 10/1/2015 7:29:15 AM
Cellectar Biosciences  (NVLT) Announces Pricing Of $3.3 Million Financing 9/28/2015 7:41:34 AM
Cellectar Biosciences  (NVLT) To Present At The Ladenburg Thalmann 2015 Healthcare Conference 9/25/2015 8:10:40 AM
Cellectar Biosciences  (NVLT) To Present At The Rodman & Renshaw 17th Annual Global Investment Conference 9/3/2015 7:24:08 AM
Cellectar Biosciences  (NVLT) Introduces Phospholipid Ether-Drug Conjugate (PDC) Platform For Targeted Delivery Of Chemotherapeutics 8/21/2015 7:35:45 AM
Cellectar Biosciences  (NVLT) Announces 2nd Quarter Financial Results 8/13/2015 12:11:22 PM
Cellectar Biosciences  (NVLT) To Host Conference Call On August 12th To Discuss Second Quarter Financial Results And Provide Update On Development Plans 8/7/2015 12:41:04 PM
Cellectar Biosciences  (NVLT) Appoints Industry Veteran Jim Caruso President And Chief Executive Officer 6/16/2015 7:39:33 AM
Cellectar Biosciences  (NVLT) Announces CLR1502 Development Program To Be Classified As Combination Product By FDA 6/12/2015 7:45:21 AM